Volume 127, Issue 5, Pages (November 2004)

Slides:



Advertisements
Similar presentations
Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein.
Advertisements

Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 56, Issue 5, Pages (November 1999)
Volume 132, Issue 1, Pages (January 2007)
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Volume 127, Issue 5, Pages (November 2004)
Volume 124, Issue 5, Pages (May 2003)
UV as an Amplifier Rather Than Inducer of NF-κB Activity
Arterioscler Thromb Vasc Biol
Volume 127, Issue 3, Pages (September 2004)
Volume 127, Issue 5, Pages (November 2004)
Volume 133, Issue 6, Pages (December 2007)
Volume 126, Issue 5, Pages (May 2004)
Volume 133, Issue 2, Pages (August 2007)
Volume 131, Issue 1, Pages (July 2006)
Volume 129, Issue 2, Pages (August 2005)
Volume 134, Issue 4, Pages (April 2008)
Volume 126, Issue 1, Pages (January 2004)
Volume 118, Issue 4, Pages (April 2000)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 128, Issue 1, Pages (January 2005)
Volume 136, Issue 1, Pages (January 2009)
Volume 122, Issue 4, Pages (April 2002)
Volume 124, Issue 5, Pages (May 2003)
Volume 129, Issue 1, Pages (July 2005)
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Volume 133, Issue 6, Pages (December 2007)
Michael K. Wendt, Luke J. Drury, Rebecca A. Vongsa, Michael B. Dwinell 
Volume 134, Issue 7, Pages (June 2008)
Volume 132, Issue 1, Pages (January 2007)
Volume 124, Issue 5, Pages (May 2003)
Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: Role of iNOS and COX-2  Silvia Resta–Lenert, Kim E. Barrett 
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 126, Issue 1, Pages (January 2004)
Volume 129, Issue 2, Pages (August 2005)
Volume 56, Issue 5, Pages (November 1999)
Volume 129, Issue 3, Pages (September 2005)
Volume 116, Issue 6, Pages (June 1999)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 131, Issue 4, Pages (October 2006)
Volume 127, Issue 1, Pages (July 2004)
Volume 130, Issue 1, Pages (January 2006)
Volume 132, Issue 4, Pages (April 2007)
Volume 128, Issue 5, Pages (May 2005)
Volume 127, Issue 5, Pages (November 2004)
This month in Gastroenterology
Volume 119, Issue 2, Pages (August 2000)
Volume 136, Issue 3, Pages e2 (March 2009)
Volume 129, Issue 5, Pages (November 2005)
Volume 127, Issue 5, Pages (November 2004)
Volume 128, Issue 4, Pages (April 2005)
Volume 132, Issue 5, Pages (May 2007)
Histamine Enhances the Production of Granulocyte-Macrophage Colony-Stimulating Factor via Protein Kinase Cα and Extracellular Signal-Regulated Kinase.
Volume 120, Issue 2, Pages (February 2001)
Volume 128, Issue 1, Pages (January 2005)
Volume 1, Issue 4, Pages (June 2007)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 125, Issue 4, Pages (October 2003)
Volume 127, Issue 4, Pages (October 2004)
Volume 126, Issue 4, Pages (April 2004)
Volume 119, Issue 1, Pages (July 2000)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells  Mustapha Si-Tahar, Didier Merlin,
Volume 122, Issue 1, Pages (January 2002)
Volume 67, Issue 6, Pages (June 2005)
Volume 119, Issue 5, Pages (November 2000)
Intestinal myofibroblasts in innate immune responses of the intestine
Volume 124, Issue 5, Pages (May 2003)
The human colonic monocarboxylate transporter Isoform 1: Its potential importance to colonic tissue homeostasis  Mark Cuff, Jane Dyer, Mark Jones, Soraya.
Volume 128, Issue 4, Pages (April 2005)
Presentation transcript:

Volume 127, Issue 5, Pages 1474-1487 (November 2004) Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition  Elaine O. Petrof, Keishi Kojima, Mark J. Ropeleski, Mark W. Musch, Yun Tao, Claudio De Simone, Eugene B. Chang  Gastroenterology  Volume 127, Issue 5, Pages 1474-1487 (November 2004) DOI: 10.1053/j.gastro.2004.09.001 Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 1 Probiotic-conditioned medium inhibits TNF-α stimulation of NF-κB. YAMC cells were transfected with an NF-κB luciferase reporter gene and treated with VSL#3-conditioned media for 16 hours and then stimulated with TNF-α (50 ng/mL 6 hours before harvest). Experimental conditions are as indicated below each column. Transfections were performed in triplicate for each experimental condition (n = 8), with the exception of the column showing VSL treatment alone; these data were compiled from 3 separate experiments, also performed in triplicate for each experiment. Data are expressed as mean ± SE (*P < .05 compared with TNF-treated samples). Activity is expressed in arbitrary luminescence units, normalized to the thymidine kinase-Renilla internal control. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 2 Probiotic-conditioned medium inhibits MCP-1 release. YAMC cells were treated with VSL#3-conditioned media (VSL-CM) for 16 hours, stimulated with TNF-α (50 ng/mL) 6 hours before harvest, and compared with untreated control cells (No Tx), cells treated with TNF-α alone (TNF-α only), or cells pretreated with conditioned media from the E coli strain DH5α with and without TNF-α. Supernatants were assayed for release of the chemokine MCP-1 by enzyme-linked immunosorbent assay (see the Materials and Methods section). Experimental conditions are as indicated below each column. YAMC cells pretreated with VSL-CM showed a reduction in the amount of MCP-1 released in response to TNF-α stimulation compared with controls (mean ± SE for 3 separate experiments; each experiment in each group was performed in triplicate; *P < .05 compared with controls). Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 3 Probiotic-conditioned medium stabilizes and prevents degradation of IκBα. YAMC cells were treated with VSL#3-conditioned media for 16 hours and then stimulated with TNF-α (50 ng/mL) and harvested at the times indicated. (Upper panel) TNF-α stimulates transient phosphorylation of IκBα (5 minutes) and is associated with decreased total IκBα (5–15 minutes) as IκBα is targeted for degradation. (Bottom panel) Pretreatment of YAMC cells with VSL#3-conditioned media inhibits the effects of TNF-α on IκBα, thus preventing its degradation. Note the persistence of the phosphorylated form of IκBα. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 4 Global ubiquitination is not inhibited by VSL#3-conditioned media. Immunoblot analysis of ubiquitinated proteins from YAMC cells after treatment with VSL-CM for 16 hours shows that global blockade of ubiquitination does not occur when cells are treated with VSL-CM. MG132, a compound known to inhibit proteasome function and increase the accumulation of ubiquitinated proteins, is also shown, as is thermal stress (HS). The pattern of ubiquitinated proteins observed after VSL-CM treatment most closely resembles the pattern seen with thermal stress. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 5 Probiotic-conditioned medium modulates proteasome activity. VSL has a dramatic inhibitory effect on the chymotrypsin-like activity, no inhibitory effect on the trypsin-like activity, and a partial inhibitory effect on the caspase-like activity of the proteasome. (A) YAMC cells were treated with VSL#3-conditioned media for 16 hours and then analyzed for chymotrypsin-like proteasome activity. Fluorescence is expressed in arbitrary units over time. As a positive inhibitor control, MG132 was used at a concentration of 25 μmol/L, as described in Materials and Methods. Experimental conditions are as indicated, with data expressed as means and error bars expressed as SEM (n = 6). For the trypsin-like (B) and caspase-like (C) activity, YAMC cells were treated with VSL#3-conditioned media for 16 hours and then analyzed as described, but instead of MG132, the proteasome inhibitor lactacystin was used at a concentration of 10 μmol/L (use of higher concentrations of lactacystin was limited because of cell toxicity). Data are expressed as means for 3 separate experiments, with error bars expressed as SEM. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 6 Proteasome inhibition by probiotic-conditioned media is an early event. The time course of VSL#3-CM treatment shows that proteasome inhibition by VSL#3-CM is an early event that occurs almost immediately after exposure of epithelial cells to the probiotic-conditioned media. YAMC cells were treated for 30 minutes, 60 minutes, and 6 hours, and then they were harvested and assayed for their ability to inhibit the cytotoxic T lymphocyte-like activity of the proteasome. Slopes of each assay, which represent the degree of proteasome activity, were determined for each time point and plotted over time. The most pronounced proteasome inhibition occurs early after treatment with VSL#3-CM, and most of the inhibition occurs within the first 30 minutes. Shown is a graph representative of 3 separate experiments. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 7 Probiotic-conditioned medium inhibits the degradation of other proteins involved in the NF-κB pathway that are normally degraded by the proteasome, and this is an early event. YAMC cells were treated with VSL#3-CM for 1 hour, and then they were stimulated with TNF-α and harvested at the times indicated. (A, top panel) TNF-α stimulation was associated with decreased total IκBβ (10–60 minutes) as IκBβ was targeted for degradation by the proteasome. (Bottom panel) Pretreatment of YAMC cells with VSL#3-CM for only 1 hour inhibits the effects of TNF-α and prevents degradation of IκBβ. One hour of pretreatment with VSL#3-CM was similarly found to inhibit the degradation of the precursor p105, which is normally degraded by the proteasome after stimulation with TNF-α (B), thus providing further support that VSL#3-CM inhibits epithelial cell proteasome function early after probiotic exposure. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 8 Hsp25 and hsp72 expression is induced by probiotics, does not involve cell wall components, and is specific to epithelial cell types. (A) Immunoblot analysis of levels of hsp25 and hsp72 in YAMC cells after exposure to VSL#3 bacteria for the times indicated shows a time-dependent increase in hsp expression. (Last 2 lanes) 48h, untreated controls harvested at 48 hours; HS, heat-shocked cells (positive controls). Hsc73 (heat shock cognate 73) served as a loading control. (B) Immunoblot analysis of levels of hsp25 and hsp72 in YAMC cells after exposure to VSL#3-conditioned media (CM) or sonicated organisms at the concentrations of bacteria indicated (colony-forming units [cfu] per milliliter). Bacteria were grown as described in Materials and Methods and were then separated into either a CM fraction or sonicated pellet (Pellet). A concentration-dependent increase in hsp expression can be seen on exposure to VSL#3-CM that was not seen with sonicated pellet, thus indicating that the active factors produced by the bacteria are secreted into CM and are not cell wall components. Hsc73 served as a loading control. (C) Immunoblot analysis of hsp72, comparing different cell lines after exposure to VSL#3-CM for 16 hours (20 μg of protein per lane). VSL#3-CM induces a robust hsp72 response in both colonic (YAMC) and small-intestinal (MSIE) epithelial cells that is not seen in 3T3 fibroblast cells, suggesting that the probiotic effect is specific to epithelial cells. Thermal stress (HS) served as a positive control. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 9 Hsp induction by probiotics is at least partly transcriptional and involves HSF-1. (A) Electrophoretic mobility shift assays (EMSAs) show that the induction of hsp expression by VSL#3-CM was transcriptional. YAMC cells were treated for the times indicated with VSL#3-CM and then harvested; EMSAs were performed as described in Materials and Methods. VSL#3-CM induced binding of HSF, reaching a maximal signal approximately 4 or 5 hours after exposure and then tapering off after 6 hours; this indicates that hsp induction by VSL#3-CM is at least partly transcriptional. (B) EMSA showing the specificity of this binding by using antibodies against the transcription factors HSF-1 and HSF-2. The major transcription factor involved in hsp induction by VSL#3-CM is HSF-1; HSF-2 does not seem to play a role. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 10 The time course of hsp induction by the proteasome inhibitor MG132 is similar to that produced by VSL#3-conditioned media. Immunoblot analysis of hsp25 and hsp72 levels in YAMC cells (20 μg of protein per lane) after exposure to the proteasome inhibitor MG132 (25 μmol/L) for the times indicated showed a time-dependent increase in hsp expression that paralleled that seen with VSL#3-treated cells. (First 2 lanes) C, untreated control harvested at 0 hours; V, dimethyl sulfoxide vehicle-treated control harvested at 14 hours; HS, heat-shocked cells (positive control). MG132 was even more effective than heat shock at inducing hsp25. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions

Figure 11 Probiotic-conditioned medium protects epithelial cells against oxidant stress. (A) Chromium release assay showing that VSL#3-CM protects YAMC cells from oxidant injury. YAMC cells were treated with VSL#3-CM for 16 hours. Cells were labeled with 51Cr for 60 minutes and stimulated with monochloramine (NH2Cl; 0.6 mmol/L) for 60 minutes, and the ratio of released 51Cr to intracellular 51Cr was determined (mean ± SE for 3 separate experiments; each experiment in each group was performed in triplicate; *P < .05 compared with controls). (B) VSL#3-CM prevents oxidant-induced actin depolymerization from F to G actin. YAMC cells were treated with VSL#3-CM for 16 hours, when appropriate, and were then treated with the oxidant NH2Cl (0.6 mmol/L; 60 minutes) along with untreated control (Con) cells. Cells were processed for globular (G) and filamentous (F) actin as described in Materials and Methods. Images shown are representative of 3 separate experiments. Gastroenterology 2004 127, 1474-1487DOI: (10.1053/j.gastro.2004.09.001) Copyright © 2004 American Gastroenterological Association Terms and Conditions